Andrei Turbatu, Camelia Dobrea, Marilena Stoian, Cristian Tudor Barta, Georgian Halcu, Adelina Birceanu, Ana-Maria Bordea, Cecilia Gabriela Ghimici, Mădălina Marilena Oprea, Livia Doria Neacșu, Anca-Roxana Lupu, Andrei Coliță
Hodgkin lymphoma (HL) has become one of the most curable hematological neoplasia. Clinical and biological factors remain the main pillars guiding therapeutic strategies in HL. Recent studies have improved our understanding of the phenotype, the characteristics of histogenesis, and other possible mechanisms of lymphomagenesis, including the role of Epstein-Barr virus (EBV) infection. Tumor cells manipulate the microenvironment, allowing them to develop their malignant phenotype and evade the attack of the host's immune response so that the interaction between tumor cells and the reactive microenvironment determines not only the histological features but also the clinical-pathological characteristics and prognosis of these patients - essential for the development of future therapies targeting various other cellular components of the tumor microenvironment...
August 2023: Journal of Medicine and Life